Clinical practice guideline on the management of patients with dyspepsia. Update 2012;Guía de práctica clínica sobre el manejo del paciente con dispepsia. Actualización 2012

Atencion Primaria

Volumn 44, Issue 12, 2012, Pages

  Gisbert, Javier P ^a   Calvet, Xavier ^b   Ferrándiz, Juan ^c   Mascort, Juan ^d   Alonso Coello, Pablo ^e   Marzo, Mercè ^d  

^a HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c Servicio Madrileño de Salud   (Spain)

^d INSTITUT CATALÀ DE LA SALUT   (Spain)

^e BIOMEDICAL RESEARCH INSTITUTE SANT PAU IIB SANT PAU   (Spain)

Author keywords

Clinical guideline; Dyspepsia; Helicobacter pylori

Indexed keywords

ARTICLE; CLINICAL DECISION MAKING; DISEASE CLASSIFICATION; DYSPEPSIA; ENDOSCOPY; HEALTH CARE UTILIZATION; HELICOBACTER INFECTION; HUMAN; PATIENT REFERRAL; PEPTIC ULCER; PRACTICE GUIDELINE;

ALGORITHMS; DYSPEPSIA; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS;

EID: 84870248524     PISSN: 02126567     EISSN: 15781275     Source Type: Journal    
DOI: 10.1016/j.aprim.2012.05.003     Document Type: Article

References (256)

1. o 2006/0I
2. M. Marzo Castillejo, and A. Montaño Barrientos El sistema GRADE para la toma de decisiones clínicas y la elaboración de recomendaciones y guías de práctica clínica Aten Primaria 39 2007 457 460
3. J.P. Gisbert, P. Alonso-Coello, and J.M. Piqué [How can we find, design, evaluate and use clinical practice guidelines?.] Gastroenterol Hepatol 31 2008 239 257
4. G.H. Guyatt, A.D. Oxman, G. Vist, R. Kunz, Y. Falck-Ytter, P. Alonso-Coello GRADE Working Group Rating quality of evidence and strength of recommendations GRADE: an emerging consensus on rating quality of evidence and strength of recommendations BMJ 336 2008 924 926
5. G.H. Guyatt, A.D. Oxman, R. Kunz, G.E. Vist, Y. Falck-Ytter, H.J. Schünemann GRADE Working Group Rating quality of evidence and strength of recommendations: What is "quality of evidence" and why is it important to clinicians? BMJ 336 2008 995 998
6. H.J. Schünemann, A.D. Oxman, J. Brozek, P. Glasziou, R. Jaeschke, G.E. Vist GRADE Working Group Grading quality of evidence and strength of recommendations for diagnostic tests and strategies BMJ 336 2008 1106 1110
7. G.H. Guyatt, A.D. Oxman, R. Kunz, R. Jaeschke, M. Helfand, A. Liberati GRADE working group Rating quality of evidence and strength of recommendations: Incorporating considerations of resources use into grading recommendations BMJ 336 2008 1170 1173
8. G.H. Guyatt, A.D. Oxman, R. Kunz, Y. Falck-Ytter, G.E. Vist, A. Liberati GRADE Working Group Rating quality of evidence and strength of recommendations: Going from evidence to recommendations BMJ 336 2008 1049 1051
9. N.J. Talley, and R.S. Choung Whither dyspepsia?. A historical perspective of functional dyspepsia, and concepts of pathogenesis and therapy in 2009 J Gastroenterol Hepatol 24 Suppl. 3 2009 S20 S28
10. Scottish Intercollegiate Guidelines Network (SIGN) Dyspepsia. A national clinical guideline 2007 SIGN Edinburgh (SIGN publication no. 67)
11. American Gastroenterological Association Medical Position Statement: Evaluation of Dyspepsia Gastroenterology 129 2005 1753 1755
12. S.J. Veldhuyzen van Zanten, M. Bradette, N. Chiba, D. Armstrong, A. Barkun, and N. Flook Evidence-based recommendations for short and long term management of uninvestigated dyspepsia in primary care: an update of the Canadian Dyspepsia Working Group (CanDys) clinical management tool Can J Gastroenterol 19 2005 285 303
13. Dyspepsia - Management of Dyspepsia in Adults in Primary Care - Full Guidelines CG17 2004. London: NICE. Available: http://www.nice.org.uk/page.aspx? o=218381. Accessed 10 noviembre de 2010.
14. D.G. Colin-Jones, B. Bloom, G. Bodemar, G. Crean, J. Frenston, and R. Ginger Management of dyspepsia: Report of a working party Lancet 1 1988 576 579
15. J. Tack, N.J. Talley, M. Camilleri, G. Holtmann, P. Hu, and J.R. Malagelada Functional gastroduodenal disorders: a working team report for the Rome III consensus on functional gastrointestinal disorders Gastroenterology 130 2006 1466 1479
16. D.A. Drossman The functional gastrointestinal disorders and the Rome III process Gastroenterology 130 2006 1377 1390
17. J.E. Kellow Organic causes of dyspepsia, and discriminating functional from organic dyspepsia Best Pract Res Clin Gastroenterol 15 2001 477 487
18. Longstreth GF. Approach to the patient with dyspepsia. En: Talley NJ, editor. This topic last updated: july 22, 2010. Uptodate. http://www.uptodate. com/home/index.html
19. L.A. van Kerkhoven, R.J. Laheij, V. Meineche-Schmidt, S.J. Veldhuyzen-van Zanten, N.J. de Wit, and J.B. Jansen Functional dyspepsia: not all roads seem to lead to Rome J Clin Gastroenterol 43 2009 118 122
20. R.C. Heading Prevalence of upper gastrointestinal symptoms in the general population: a systematic review Scand J Gastroenterol Suppl 231 1999 3 8
21. H.B. El-Serag, and N.J. Talley Systemic review: the prevalence and clinical course of functional dyspepsia Aliment Pharmacol Ther 19 2004 643 654
22. S. Mahadeva, and K.L. Goh Epidemiology of functional dyspepsia: a global perspective World J Gastroenterol 12 2006 2661 2666
23. A.M. Caballero Plasencia, S. Sofos Kontoyannis, J.L. Martín Ruiz, and M. Valenzuela Barranco La prevalencia de la dispepsia en España Med Clin (Barc) 103 1994 717
24. N.J. Talley, M.D. Silverstein, L. Agreus, O. Nyren, A. Sonnenberg, and G. Holtmann AGA technical review: evaluation of dyspepsia. American Gastroenterological Association Gastroenterology 114 1998 582 595
25. R.S. Fisher, and H.P. Parkman Management of non ulcer dyspepsia N Engl J Med 339 1998 1376 1381
26. A.C. Ford, A. Marwaha, A. Lim, and P. Moayyedi What is the prevalence of clinically significant endoscopic findings in subjects with dyspepsia? Systematic review and meta-analysis Clin Gastroenterol Hepatol 8 2010 830 837
27. M. Barenys, R. Rota, V. Moreno, R. Villafafila, I. García-Bayo, and A. Abad [Prospective validation of a clinical scoring system for the diagnosis of organic dyspepsia] Med Clin (Barc) 121 2003 766 771
28. N.J. Talley Dyspepsia: management guidelines for the millennium Gut 50 Suppl. 4 2002 72 78
29. A.P. Hungin, C. Hill, and A. Raghunath Systematic review: frequency and reasons for consultation for gastro-oesophageal reflux disease and dyspepsia Aliment Pharmacol Ther 30 2009 331 342 15
30. J.L. Turabian, and V. Gutiérrez Variaciones en la frecuencia de las enfermedades crónicas y los factores de riesgo en atención primaria: 1985-1995 Aten Primaria 18 1996 65 69
31. R.A. Brook, N.L. Kleinman, R.S. Choung, A.K. Melkonian, J.E. Smeeding, and N.J. Talley Functional dyspepsia impacts absenteeism and direct and indirect costs Clin Gastroenterol Hepatol 8 2010 498 503
32. K. Mimidis, and J. Tack Pathogenesis of dyspepsia Dig Dis 26 2008 194 202
33. M.M. Tielemans, T. Eikendal, J.B. Jansen, and van Oijen Identification of NSAID users at risk for gastrointestinal complications: a systematic review of current guidelines and consensus agreements Drug Saf 33 2010 443 453
34. T. Furuta, and J.C. Delchier Helicobacter pylori and non-malignant diseases Helicobacter 14 Suppl. 1 2009 29 35
35. K.E. McColl Clinical practice. Helicobacter pylori infection N Engl J Med 362 2010 1597 1604
36. W.M. Priebe, L.R. DaCosta, and I.T. Beck Is epigastric tenderness a sign of peptic ulcer disease? Gastroenterology 82 1982 16 19
37. M.E. Numans, Y. Van der Graaf, N.J. de Wit, F. Touw-Otten, and R.A. de Melker How much ulcer is ulcer-like? Diagnostic determinants of peptic ulcer in open access gastroscopy Fam Pract 11 1994 382 388
38. M. Barenys, A. Abad, J.M. Pons, V. Moreno, R. Rota, and A. Granados Scoring system has better discriminative value than Helicobacter pylori testing in patients with dyspepsia in a setting with high prevalence of infection Eur J Gastroenterol Hepatol 12 2000 1275 1282
39. T. Johannessen, H. Petersen, P.M. Kleveland, J.H. Dybdahl, A.K. Sandvik, and E. Brenna The predictive value of history in dyspepsia Scand J Gastroenterol 25 1990 689 697
40. J.W. Muris, R. Starmans, P. Pop, H.F. Crebolder, and J.A. Knottnerus Discriminant value of symptoms in patients with dyspepsia J Fam Pract 38 1994 139 143
41. P. Bytzer, J.M. Hansen, T. Havelund, A. Malchow-Moller, and O.B. Schaffalitzky de Muckadell Predicting endoscopic diagnosis in the dyspeptic patient: the value of clinical judgement Eur J Gastroenterol Hepatol 8 1996 359 363
42. J.M. Hansen, P. Bytzer, and O.B. Schaffalitzky De Muckadell Management of dyspeptic patients in primary care. Value of the unaided clinical diagnosis and of dyspepsia subgrouping Scand J Gastroenterol 33 1998 799 805
43. M. Bustamante, M.J. Ferrando, F. Devesa, and A. Borghol The prediction of the endoscopic diagnosis in the dyspepsia patient: the value of the predominating presenting symptom and the initial clinical presumption Gastroenterol Hepatol 23 2000 66 70
44. M. Heikkinen, P. Pikkarainen, M. Eskelinen, and R. Julkunen GPs' ability to diagnose dyspepsia based only on physical examination and patient history Scand J Prim Health Care 18 2000 99 104
45. P. Moayyedi, N.J. Talley, M.B. Fennerty, and N. Vakil Can the clinical history distinguish between organic and functional dyspepsia? JAMA 295 2006 1566 1576
46. Danish dyspepsia study group Value of the unaided clinical diagnosis in dyspeptic patients in primary care Am J Gastroenterol 96 2001 1417 1421
47. R.C. Heading, E. Wager, and P.J. Tooley Reliability of symptom assessment in dyspepsia Eur J Gastroenterol Hepatol 9 1997 779 781
48. J.I. Westbrook, J.H. McIntosh, and J.M. Duggan Accuracy of provisional diagnoses of dyspepsia in patients undergoing first endoscopy Gastrointest Endosc 53 2001 283 288
49. J.C. Wu, F.K. Chan, J.Y. Ching, W.K. Leung, Y.T. Lee, and J.J. Sung Empirical treatment based on "typical" reflux symptoms is inappropriate in a population with a high prevalence of Helicobacter pylori infection Gastrointest Endosc 55 2002 461 465
50. M. Ponce, X. Calvet, M. Gallach, J. Ponce Grupo de Estudio de Esofagitis de la Asociación Española de Gastroenterología Prevalencia de esofagitis grave en España Gastroenterol Hepatol 31 2008 150
51. Institute for Clinical Systems Improvement. Health Care Guideline: Dyspepsia. Institute for Clinical Systems Improvement, 2002. http://www.icsi.org/guide/Dyspep.pdf
52. Aymerich M, Baena JM, Boix C, Carrillo R, Madrilejos R, Mascort JJ, et al. Direcció clínica en l'atenció primària. Dispepsia - H. pylori. Guies de pràctica clínica i material docent. (Monografía en Internet) 2005 (citado enero 2011). Disponible en: http://www.gencat. net/ics/professionals/guies/dispepsia/dispepsia.htm
53. S.J.O. Veldhuyzen van Zanten, N. Flook, N. Chiba, D. Armstrong, A. Barkun, M. Bradette the Canadian Dyspepsia Working Group An evidence-based approach to the management of uninvestigated dyspepsia in the era of Helicobacter pylori CMAJ 162 12 Suppl 2000 S1 S23
54. SBU - The Swedish Council on Technology Assessment in Health Care Stomach Pain - Evidence-Based Methods in the Diagnosis and Treatment of Dyspepsia Stockholm 2000 63.1
55. Alberta Clinical Practice Guideline Working Group. Guideline for Diagnosis and Treatment of Chronic Undiagnosed Dyspepsia in Adults. The Alberta Clinical Guideline Program, June 2000.
56. British Gastroenterology Society Dyspepsia Management Guidelines 2002 The Society London http://www.bsg.org.uk/pdf-word-docs/dyspepsia.doc
57. R.P. Adang, A.W. Ambergen, J.L. Talmon, A. Hasman, J.F. Vismans, and R.W. Stockbrugger The discriminative value of patient characteristics and dyspeptic symptoms for upper gastrointestinal endoscopic findings: a study on the clinical presentation of 1,147 patients Digestion 57 1996 118 134
58. B. Williams, M. Luckas, J.H. Ellingham, A. Dain, and A.C. Wicks Do young patients with dyspepsia need investigation? Lancet 2 1988 1349 1351
59. J. Christie, N.A. Shepherd, B.W. Codling, and R.M. Valori Gastric cancer below the age of 55: implications for screening patients with uncomplicated dyspepsia Gut 41 1997 513 517
60. D. Gillen, and K.E. McColl Does concern about missing malignancy justify endoscopy in uncomplicated dyspepsia in patients aged less than 55? Am J Gastroenterol 94 1999 75 79
61. A. Heaney, J.S. Collins, T.C. Tham, P.R. Watson, J.R. McFarland, and K.B. Bamford A prospective study of the management of the young Helicobacter pylori negative dyspeptic patient-can gastroscopies be saved in clinical practice? Eur J Gastroenterol Hepatol 10 1998 953 956
62. C. Canga 3rd, and N. Vakil Upper GI malignancy, uncomplicated dyspepsia, and the age threshold for early endoscopy Am J Gastroenterol 97 2002 600 603
63. J.J. Ofman, and L. Rabeneck The effectiveness of endoscopy in the management of dyspepsia: a qualitative systematic review Am J Med 106 1999 335 346
64. M.T. Hallissey, W.H. Allum, A.J. Jewkes, D.J. Ellis, and J.W. Fielding Early detection of gastric cancer BMJ 301 1990 513 515
65. H.M. Sue-Ling, D. Johnston, I.G. Martin, M.F. Dixon, M.R. Lansdown, and M.J. McMahon Gastric cancer: a curable disease in Britain BMJ 307 1993 591 596
66. L.G. Madsen, and P. Bytzer The value of alarm features in identifying organic causes of dyspepsia Can J Gastroenterol 14 2000 713 720
67. N.J. Talley, N. Vakil the Practice Parameters Committee of the American College of Gastroenterology Guidelines for the Management of Dyspepsia Am J Gastroenterol 100 2005 2324 2337
68. N.P. Breslin, A.B. Thomson, R.J. Bailey, P.K. Blustein, J. Meddings, and E. Lalor Gastric cancer and other endoscopic diagnoses in patients with benign dyspepsia Gut 46 2000 93 97
69. I.G. Martin, S. Young, H.M. Sue-Ling, and D. Johnston Delays in the diagnosis ofoesophagogastric cancer: a consecutive case series BMJ 314 1997 467 471
70. S.M. Griffin, and S.A. Raimes Proton pump inhibitors may mask early gastric cancer. Dyspeptic patients over 45 should undergo endoscopy before thesedrugs are started BMJ 317 1998 1606 1607
71. Z. Suvakovic, M.G. Bramble, R. Jones, C. Wilson, N. Idle, and J. Ryott Improving the detection rate of early gastric cancer requires more than open access gastroscopy: a five year study Gut 41 1997 308 313
72. M.G. Bramble, Z. Suvakovic, and A.P. Hungin Detection of upper gastrointestinal cancer in patients taking antisecretory therapy prior to gastroscopy Gut 46 2000 464 467
73. A.T. Lassen, F.M. Pedersen, P. Bytzer, and O.B. Schaffalitzky de Muckadell Helicobacter pylori test-and-eradicate versus prompt endoscopy for management of dyspeptic patients: a randomised trial Lancet 356 2000 455 460
74. R.J. Laheij, J.L. Severens, E.H. Van de Lisdonk, A.L. Verbeek, and J.B. Jansen Randomized controlled trial of omeprazole or endoscopy in patients with persistent dyspepsia: a cost-effectiveness analysis Aliment Pharmacol Ther 12 1998 1249 1256
75. J.M. Pajares Helicobacter pylori infection and gastric cancer in Spain Hepatogastroenterology 48 2001 1556 1559
76. NHS Executive Referral Guidelines for Suspected Cancer. London: HMSO, 2000.
77. W.H. Allum, S.M. Griffin, A. Watson, and D. Colin-Jones Guidelines for the management of oesophageal and gastric cancer Gut 50 2002 v1 v2
78. N. Kapoor, A. Bassi, R. Sturgess, and K. Bodger Predictive value of alarm features in a rapid access upper gastrointestinal cancer service Gut 54 2005 40 45
79. Globocan. http://globocan.iarc.fr/factsheets/populations/factsheet.asp? uno=724. Accessed 5 julio de 2011.
80. P. Paré, J. Lee, and I.A. Hawes Counselling by primary care physicians may help patients with heartburn-predominant uninvestigated dyspepsia Can J Gastroenterol 24 2010 189 195
81. N. Chiba, S.J. Van Zanten, P. Sinclair, R.A. Ferguson, S. Escobedo, and E. Grace Treating Helicobacter pylori infection in primary care patients with uninvestigated dyspepsia: the Canadian adult dyspepsia empiric treatment-Helicobacter pylori positive (CADET-Hp) randomised controlled trial BMJ 324 2002 1012 1016
82. M. Färkkilä, S. Sarna, V. Valtonen, P. Sipponen PROSPER Study Group Does the 'test-and-treat' strategy work in primary health care for management of uninvestigated dyspepsia? A prospective two-year follow-up study of 1552 patients Scand J Gastroenterol 39 2004 327 335
83. A. Heaney, J.S. Collins, R.G. Watson, R.J. McFarland, K.B. Bamford, and T.C. Tham A prospective randomised trial of a "test and treat" policy versus endoscopy based management in young Helicobacter pylori positive patients with ulcer-like dyspepsia, referred to a hospital clinic Gut 45 1999 186 190
84. J.A. Lane, L.J. Murray, S. Noble, M. Egger, I.M. Harvey, and J.L. Donovan Impact of Helicobacter pylori eradication on dyspepsia, health resource use, and quality of life in the Bristol helicobacter project: randomised controlled trial BMJ 332 2006 199 204
85. A.C. Ford, D. Forman, A.G. Bailey, A.T. Axon, and P. Moayyedi A community screening program for Helicobacter pylori saves money: 10-year follow-up of a randomized controlled trial Gastroenterology 129 2005 1910 1917
86. R.F. Harvey, J.A. Lane, P. Nair, M. Egger, I. Harvey, and J. Donovan Clinical trial: prolonged beneficial effect of Helicobacter pylori eradication on dyspepsia consultations - the Bristol Helicobacter Project Aliment Pharmacol Ther 32 2010 394 400
87. J.P. Gisbert, and J.M. Pajares Helicobacter pylori test-and-treat' strategy for dyspeptic patients Scand J Gastroenterol 34 1999 644 652
88. J.P. Gisbert, X. Badía, M. Roset, and J.M. Pajares The TETRA study: a prospective evaluation of Helicobacter pylori 'test-and-treat' strategy on 736 patients in clinical practice Helicobacter 9 2004 28 38
89. X. Calvet, J. Sánchez-Delgado, A. Montserrat, S. Lario, M.J. Ramírez-Lázaro, and M. Quesada Accuracy of diagnostic tests for Helicobacter pylori: a reappraisal Clin Infect Dis 48 2009 1385 1391
90. J.E. Domínguez-Muñoz, A. Leodolter, T. Sauerbruch, and P. Malfertheiner A citric acid solution is an optimal test drink in the 13C-urea breath test for the diagnosis of Helicobacter pylori infection Gut 40 1997 459 462
91. J.P. Gisbert, and J.M. Pajares 13C-urea breath test in the management of Helicobacter pylori infection Dig Liver Dis 37 2005 899 906
92. D.Y. Graham, and P.D. Klein Accurate diagnosis of Helicobacter pylori. 13C-urea breath test Gastroenterol Clin North Am 29 2000 885 893
93. J.P. Gisbert, and J.M. Pajares Review article: 13C-urea breath test in the diagnosis of Helicobacter pylori infection - a critical review Aliment Pharmacol Ther 20 2004 1001 1017
94. E. Gené, J. Sánchez-Delgado, X. Calvet, and R. Azagra Manejo de la infección por Helicobacter pylori en atención primaria en España Gastroenterol Hepatol 31 2008 327 334
95. G. Manes, A. Menchise, C. de Nucci, and A. Balzano Empirical prescribing for dyspepsia: randomised controlled trial of test and treat versus omeprazole treatment BMJ 326 2003 1118
96. L. Rabeneck, J. Souchek, K. Wristers, T. Menke, E. Ambriz, and I. Huang A double blind, randomized, placebo-controlled trial of proton pump inhibitor therapy in patients with uninvestigated dyspepsia Am J Gastroenterol 97 2002 3045 3051
97. P. Moayyedi, B.C. Delaney, N. Vakil, D. Forman, and N.J. Talley The efficacy of proton pump inhibitors in nonulcer dyspepsia: a systematic review and economic analysis Gastroenterology 127 2004 1329 1337
98. B. Delaney, A.C. Ford, D. Forman, P. Moayyedi, and M. Qume Initial management strategies for dyspepsia Cochrane Database Syst Rev 2005 CD001961
99. S.J. Veldhuyzen van Zanten, N. Chiba, D. Armstrong, A. Barkun, A. Thomson, and S. Smyth A randomized trial comparing omeprazole, ranitidine, cisapride, or placebo in helicobacter pylori negative, primary care patients with dyspepsia: the CADET-HN Study Am J Gastroenterol 100 2005 1477 1488
100. C.J. van Marrewijk, S. Mujakovic, G.A. Fransen, M.E. Numans, N.J. de Wit, and J.W. Muris Effect and cost-effectiveness of step-up versus step-down treatment with antacids, H2-receptor antagonists, and proton pump inhibitors in patients with new onset dyspepsia (DIAMOND study): a primary-care-based randomised controlled trial Lancet 373 2009 215 225
101. C.P. Dooley, A.W. Larson, N.H. Stace, I.G. Renner, J.E. Valenzuela, and J. Eliasoph Double-contrast barium meal and upper gastrointestinal endoscopy. A comparative study Ann Intern Med 101 1984 538 545
102. P.C. Shaw, L.K. van Romunde, G. Griffioen, A.R. Janssens, J. Kreuning, and G.A. Eilers Peptic ulcer and gastric carcinoma: diagnosis with biphasic radiography compared with fiberoptic endoscopy Radiology 163 1987 39 42
103. P.C. Shaw, I.K.I. Romunde, G. Griffioen, A.R. Janssens, J. Kreuning, and C.B.H.W. Lamers Detection of Gastric Erosions: Comparison of Biphasic Radiography With Fiberoptic Endoscopy Radiology 178 1991 63 66
104. RCR Working Party Making the best use of a Department of Clinical Radiology 4th Ed. 1998 The Royal College of Radiologists London
105. A.C. Ford, M. Qume, P. Moayyedi, N.L. Arents, A.T. Lassen, and R.F. Logan Helicobacter pylori "test and treat" or endoscopy for managing dyspepsia: an individual patient data meta-analysis Gastroenterology 128 2005 1838 1844
106. S. Mahadeva, Y.C. Chia, A. Vinothini, M. Mohazmi, and K.L. Goh Cost-effectiveness of and satisfaction with a Helicobacter pylori "test and treat" strategy compared with prompt endoscopy in young Asians with dyspepsia Gut 57 2008 1214 1220
107. A.C. Ford, D. Forman, J. Nathan, W.D. Crocombe, A.T. Axon, and P. Moayyedi Clinical trial: knowledge of negative Helicobacter pylori status reduces subsequent dyspepsia-related resource use Aliment Pharmacol Ther 26 2007 1267 1275
108. T. Smith, E. Verzola, and H. Mertz Low yield of endoscopy in patients with persistent dyspepsia taking proton pump inhibitors Gastrointest Endosc 58 2003 9 13
109. A. Barkun, R. Crott, C. Fallone, W. Kennedy, J. Lachaine, and C. Levinton A one-year economic evaluation of six alternative strategies in the management of uninvestigated upper gastrointestinal symptoms in Canadian primary care Can J Gastroenterol 24 2010 489 498
110. P.M. Barton, P. Moayyedi, N.J. Talley, N.B. Vakil, and B.C. Delaney A second-order simulation model of the cost-effectiveness of managing dyspepsia in the United States Med Decis Making 28 2008 44 55
111. H.C. Kjeldsen, M. Bech, and B. Christensen Cost-effectiveness analysis of two management strategies for dyspepsia Int J Technol Assess Health Care 23 2007 376 384
112. P. Moayyedi The health economics of Helicobacter pylori infection Best Pract Res Clin Gastroenterol 21 2007 347 361
113. R.M. Klok, N.L. Arents, R. de Vries, J.C. Thijs, J.R. Brouwers, and J.H. Kleibeuker Economic evaluation of a randomized trial comparing Helicobacter pylori test-and-treat and prompt endoscopy strategies for managing dyspepsia in a primary-care setting Clin Ther 27 2005 1647 1657
114. A. Sreedharan, M. Clough, E. Hemingbrough, L. Gatta, D.M. Chalmers, and A.T. Axon Cost-effectiveness and long-term impact of Helicobacter pylori 'test and treat' service in reducing open access endoscopy referrals Eur J Gastroenterol Hepatol 16 2004 981 986
115. R.J. Laheij, J.T. Hermsen, J.B. Jansen, A.M. Horrevorts, R.J. Rongen, and L.G. Van Rossum Empirical treatment followed by a test-and-treat strategy is more cost-effective in comparison with prompt endoscopy or radiography in patients with dyspeptic symptoms: a randomized trial in a primary care setting Fam Pract 21 2004 238 243
116. N. Makris, A. Barkun, R. Crott, and C.A. Fallone Cost-effectiveness of alternative approaches in the management of dyspepsia Int J Technol Assess Health Care 19 2003 446 464
117. P. Bytzer, J.M. Hansen, and O.B. Schaffalitzky de Muckadell Empirical H2-blocker therapy or prompt endoscopy in management of dyspepsia Lancet 343 1994 811 816
118. B.C. Delaney, S. Wilson, A. Roalfe, L. Roberts, V. Redman, and A. Wearn Cost effectiveness of initial endoscopy for dyspepsia in patients over age 50 years: a randomised controlled trial in primary care Lancet 356 2000 1965 1969
119. A.C. Ford, P. Moayyedi, D.E. Jarbol, R.F. Logan, and B.C. Delaney Meta-analysis: Helicobacter pylori 'test and treat' compared with empirical acid suppression for managing dispepsia Aliment Pharmacol Ther 28 2008 534 544
120. B.C. Delaney, M. Qume, P. Moayyedi, R.F. Logan, A.C. Ford, and C. Elliott Helicobacter pylori test and treat versus proton pump inhibitor in initial management of dyspepsia in primary care: multicentre randomised controlled trial (MRC-CUBE trial) BMJ 336 2008 651 654
121. D.E. Jarbol, M. Bech, J. Kragstrup, T. Havelund, and O.B. Schaffalitzky de Muckadell Economic evaluation of empirical antisecretory therapy versus Helicobacter pylori test for management of dyspepsia: a randomized trial in primary care Int J Technol Assess Health Care 22 2006 362 371
122. U. Ladabaum, W.D. Chey, J.M. Scheiman, and A.M. Fendrick Reappraisal of non-invasive management strategies for uninvestigated dyspepsia: a cost-minimization analysis Aliment Pharmacol Ther 16 2002 1491 1501
123. M.H. Ebell, L. Warbasse, and C. Brenner Evaluation of the dyspeptic patient: a cost-utility study Fam Pract 44 1997 545 555
124. A.M. Fendrick, M.E. Chernew, R.A. Hirth, and B.S. Bloom Alternative management strategies for patients with suspected peptic ulcer disease Ann Intern Med 123 1995 260 268
125. A. García-Altés, R. Rota, M. Barenys, A. Abad, V. Moreno, and J.M.V. Pons Cost-effectiveness of a "score and scope" strategy for the management of dyspepsia Eur J Gastroenterol Hepatol 17 2005 709 719
126. R. Macenlle García, P. Gayoso Diz, R.A. Sueiro Benavides, and J. Fernández Seara Prevalence of Helicobacter pylori infection in the general adult population of the province of Ourense Rev Esp Enferm Dig 98 2006 241 248
127. S.V. Leandro Liberato, M. Hernández Galindo, L. Torroba Alvarez, F. Sánchez Miramón, S.E. Leandro Ciriza, and A. Gómez Abadía Helicobacter pylori infection in the child population in Spain: prevalence, related factors and influence on growth An Pediatr (Barc) 63 2005 489 494
128. E.J. Kuipers, L. Lundell, E.C. Klinkenberg-Knol, N. Havu, H.P. Festen, and B. Liedman Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication N Engl J Med 334 1996 1018 1022
129. A.H. Poulsen, S. Christensen, J.K. McLaughlin, R.W. Thomsen, H.T. Sorensen, and J.H. Olsen Proton pump inhibitors and risk of gastric cancer: a population-based cohort study Br J Cancer 100 2009 1503 1507
130. H.B. Yang, B.S. Sheu, S.T. Wang, H.C. Cheng, W.L. Chang, and W.Y. Chen H. pylori eradication prevents the progression of gastric intestinal metaplasia in reflux esophagitis patients using long-term esomeprazole Am J Gastroenterol 104 2009 1642 1649
131. J.P. Gisbert, D. Boixeda, C.M. de Argila, F. Bermejo, C. Redondo, and L. de Rafael Erosive duodenitis: prevalence of Helicobacter pylori infection and response to eradication therapy with omeprazole plus two antibiotics Eur J Gastroenterol Hepatol 9 1997 957 962
132. A. O'Connor, J. Gisbert, and C. O'Morain Treatment of Helicobacter pylori infection Helicobacter 14 Suppl. 1 2009 46 51
133. J.P. Gisbert, X. Calvet, A. O'Connor, F. Megraud, and C.A. O'Morain Sequential therapy for Helicobacter pylori eradication: a critical review J Clin Gastroenterol 44 2010 313 325
134. A. O'Connor, J.P. Gisbert, D. McNamara, and C. O'Morain Treatment of Helicobacter pylori infection 2010 Helicobacter 15 Suppl. 1 2010 46 52
135. O'Connor A, Gisbert JP, McNamara D, O'Morain C. Treatment of Helicobacter pylori infection 2011. Helicobacter. 2011;16(Suppl.):53-8.
136. J.P. Gisbert Diagnosis of Helicobacter pylori infection Rev Clin Esp 200 2000 370 372
137. L. Laine, R. Estrada, M. Trujillo, K. Knigge, and M.B. Fennerty Effect of proton-pump inhibitor therapy on diagnostic testing for Helicobacter pylori Ann Intern Med 129 1998 547 550
138. S.J. Connor, M.C. Ngu, and P.H. Katelaris The impact of short-term ranitidine use on the precision of the 13C-urea breath test in subjects infected with Helicobacter pylori Eur J Gastroenterol Hepatol 11 1999 1135 1138
139. V. Savarino, D. Tracci, P. Dulbecco, M.R. Mele, P. Zentilin, and C. Mansi Negative effect of ranitidine on the results of urea breath test for the diagnosis of Helicobacter pylori Am J Gastroenterol 96 2001 348 352
140. K. Adachi, H. Fujishiro, T. Mihara, Y. Komazawa, and Y. Kinoshita Influence of lansoprazole, famotidine, roxatidine and rebamipide administration on the urea breath test for the diagnosis of Helicobacter pylori infection J Gastroenterol Hepatol 18 2003 168 171
141. L. Gatta, N. Vakil, C. Ricci, J.F. Osborn, A. Tampieri, and F. Perna Effect of proton pump inhibitors and antacid therapy on 13C urea breath tests and stool test for Helicobacter pylori infection Am J Gastroenterol 99 2004 823 829
142. K.E. Brown, and D.A. Peura Diagnosis of Helicobacter pylori infection Gastroenterol Clin North Am 22 1993 105 115
143. C.G. Kim, I.J. Choi, J.Y. Lee, S.J. Cho, B.H. Nam, and M.C. Kook Biopsy site for detecting Helicobacter pylori infection in patients with gastric cancer J Gastroenterol Hepatol 24 2009 469 474
144. L. Laine, J. Sugg, L. Suchower, and G. Neil Endoscopic biopsy requirements for post-treatment diagnosis of Helicobacter pylori Gastrointest Endosc 51 2000 664 669
145. R.M. Said, P.L. Cheah, S.C. Chin, and K.L. Goh Evaluation of a new biopsy urease test: Pronto Dry, for the diagnosis of Helicobacter pylori infection Eur J Gastroenterol Hepatol 16 2004 195 199
146. F. Bermejo San Jose, D. Boixeda de Miguel, J.P. Gisbert, C. Martin de Argila de Prados, J.M. Sanz Sacristan, and V. Defarges Pons [Efficacy of four widely used techniques of the diagnosis of Helicobacter pylori infection in gastric ulcer disease] Rev Clin Esp 200 2000 475 479
147. H. Cohen, and L. Laine Endoscopic methods for the diagnosis of Helicobacter pylori Aliment Pharmacol Ther 11 Suppl. 1 1997 3 9
148. A.F. Cutler Testing for Helicobacter pylori in clinical practice Am J Med 100 1996 35S 39S discussion 9S-41S
149. R.J. Laheij, H. Straatman, J.B. Jansen, and A.L. Verbeek Evaluation of commercially available Helicobacter pylori serology kits: a review J Clin Microbiol 36 1998 2803 2809
150. A.P. Roberts, S.M. Childs, G. Rubin, and N.J. de Wit Tests for Helicobacter pylori infection: a critical appraisal from primary care Fam Pract 17 Suppl. 2 2000 S12 S20
151. H. Cohen, S. Rose, D.N. Lewin, B. Retama, W. Naritoku, and C. Johnson Accuracy of four commercially available serologic tests, including two office-based tests and a commercially available 13C urea breath test, for diagnosis of Helicobacter pylori Helicobacter 4 1999 49 53
152. P. Herbrink, and L.J. van Doorn Serological methods for diagnosis of Helicobacter pylori infection and monitoring of eradication therapy Eur J Clin Microbiol Infect Dis 19 2000 164 173
153. J.E. Dominguez-Muñoz, A. Leodolter, T. Sauerbruch, and P. Malfertheiner A citric acid solution is an optimal test drink in the 13C-urea breath test for the diagnosis of Helicobacter pylori infection Gut 40 1997 459 462
154. J. Mones, J.P. Gisbert, F. Borda, and E. Dominguez-Muñoz Indications, diagnostic tests and Helicobacter pylori eradication therapy. Recommendations by the 2nd Spanish Consensus Conference Rev Esp Enferm Dig 97 2005 348 374
155. J.P. Gisbert, and J.M. Pajares Stool antigen test for the diagnosis of Helicobacter pylori infection: a systematic review Helicobacter 9 2004 347 368
156. J.P. Gisbert, F. de la Morena, and V. Abraira Accuracy of monoclonal stool antigen test for the diagnosis of H. pylori infection: a systematic review and meta-analysis Am J Gastroenterol 101 2006 1921 1930
157. X. Calvet, S. Lario, M.J. Ramirez-Lazaro, A. Montserrat, M. Quesada, and L. Reeves Comparative accuracy of 3 monoclonal stool tests for diagnosis of Helicobacter pylori infection among patients with dyspepsia Clin Infect Dis 50 2010 323 328
158. Malfertheiner et al. Maastricht consensus report IV, datos no publicados.(en prensa).
159. T. Rokkas, P. Sechopoulos, I. Robotis, G. Margantinis, D. Pistiolas, and H. Cumulative pylori eradication rates in clinical practice by adopting first and second-line regimens proposed by the Maastricht III consensus and a third-line empirical regimen Am J Gastroenterol 104 2009 21 25
160. J.P. Gisbert, J.L. Gisbert, S. Marcos, I. Jimenez-Alonso, R. Moreno-Otero, and J.M. Pajares Empirical rescue therapy after Helicobacter pylori treatment failure: a 10-year single-centre study of 500 patients Aliment Pharmacol Ther 27 2008 346 354
161. J.P. Gisbert Enfermedades relacionadas con H. pylori: dispepsia, úlcera y cáncer gástrico Gastroenterol Hepatol 34 Suppl. 1 2011 16 27
162. D.Y. Graham, and L. Fischbach Helicobacter pylori infection N Engl J Med 363 2010 595 596
163. D.Y. Graham, and L. Fischbach Helicobacter pylori treatment in the era of increasing antibiotic resistance Gut 59 2010 1143 1153
164. F. Megraud H pylori antibiotic resistance: prevalence, importance, and advances in testing Gut 53 2004 1374 1384
165. P. Malfertheiner, F. Megraud, C. O'Morain, F. Bazzoli, E. El-Omar, and D. Graham Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report Gut 56 2007 772 781
166. E. Pérez-Trallero, M.J. Ramírez-Lázaro, H. Villar, G. Royo, M. Montes, and S. Lario Resistencia de Helicobacter pylori a diversos antibióticos: un estudio multicéntrico español Gastroenterol Hepatol 34 2011 236
167. E. Gene, X. Calvet, R. Azagra, and J.P. Gisbert Triple vs quadruple therapy for treating Helicobacter pylori infection: an updated meta-analysis Aliment Pharmacol Ther 18 2003 543 544
168. E. Gene, X. Calvet, R. Azagra, and J.P. Gisbert Triple vs. quadruple therapy for treating Helicobacter pylori infection: a meta-analysis Aliment Pharmacol Ther 17 2003 1137 1143
169. J. Luther, P.D. Higgins, P.S. Schoenfeld, P. Moayyedi, N. Vakil, and W.D. Chey Empiric quadruple vs. triple therapy for primary treatment of Helicobacter pylori infection: Systematic review and meta-analysis of efficacy and tolerability Am J Gastroenterol 105 2010 65 73
170. P. Malfertheiner, F. Bazzoli, J.C. Delchier, K. Celiñski, M. Giguère, and M. Rivière Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline given with omeprazole versus clarithromycin-based triple therapy: a randomised, open-label, non-inferiority, phase 3 trial Lancet 377 2011 905 913
171. A. Zullo, V. De Francesco, C. Hassan, S. Morini, and D. Vaira The sequential therapy regimen for Helicobacter pylori eradication: a pooled-data analysis Gut 56 2007 1353 1357
172. P. Moayyedi Sequential regimens for Helicobacter pylori eradication Lancet 370 2007 1010 1012
173. L. Gatta, N. Vakil, G. Leandro, F. Di Mario, and D. Vaira Sequential therapy or triple therapy for Helicobacter pylori infection: systematic review and meta-analysis of randomized controlled trials in adults and children Am J Gastroenterol 104 2009 3069 3079
174. J.P. Gisbert, O.P. Nyssen, A.G. McNicholl, M. Mégraud, V. Savarino, and G. Oderda Meta-análisis de la terapia secuencial frente a la triple terapia clásica para la erradicación de Helicobacter pylori Gastroenterol Hepatol 34 2011 189
175. J. Sánchez-Delgado, X. Calvet, L. Bujanda, J.P. Gisbert, L. Tito, and M. Castro Ten-day sequential treatment for Helicobacter pylori eradication in clinical practice Am J Gastroenterol 103 2008 2220 2223
176. J. Molina-Infante, B. Perez-Gallardo, M. Fernandez-Bermejo, M. Hernandez-Alonso, G. Vinagre, and C. Duenas Clinical trial: clarithromycin vs. levofloxacin in first-line triple and sequential regimens for Helicobacter pylori eradication Aliment Pharmacol Ther 31 2010 1077 1084
177. A.S. Essa, J.R. Kramer, D.Y. Graham, and G. Treiber Meta-analysis: four-drug, three-antibiotic, non-bismuth-containing "concomitant therapy" versus triple therapy for Helicobacter pylori eradication Helicobacter 14 2009 109 118
178. D.C. Wu, P.I. Hsu, J.Y. Wu, A.R. Opekun, C.H. Kuo, and I.C. Wu Sequential and concomitant therapy with four drugs is equally effective for eradication of H pylori infection Clin Gastroenterol Hepatol 8 2010 36 41
179. J. Molina-Infante, C. Pazos-Pacheco, B. Perez-Gallardo, G. Vinagre-Rodriguez, M. Hernandez-Alonso, and C. Dueñas-Sadornil Eficacia del tratamiento empírico cuádruple "concomitante" para la infección por H. pylori en un área con una tasa elevada de resistencia a claritromicina Gastroenterol Hepatol 34 2011 179
180. J.P. Gisbert, and X. Calvet Review article: Non-bismuth quadruple (concomitant) therapy for Helicobater pylori eradication Aliment Pharmacol Ther 2011 10.1111/j.1365-2036.2011.04770.x
181. J.P. Gisbert, X. Calvet, F. Gomollon, and J. Mones [Eradication treatment of Helicobacter pylori. Recommendations of the II Spanish Consensus Conference] Med Clin (Barc) 125 2005 301 316
182. J.P. Gisbert, J.L. Gisbert, S. Marcos, D. Olivares, and J.M. Pajares Helicobacter pylori first-line treatment and rescue options in patients allergic to penicillin Aliment Pharmacol Ther 22 2005 1041 1046
183. J.P. Gisbert, A. Perez-Aisa, M. Castro-Fernandez, J. Barrio, L. Rodrigo, and A. Cosme Helicobacter pylori first-line treatment and rescue option containing levofloxacin in patients allergic to penicillin Dig Liver Dis 42 2010 287 290
184. J.P. Gisbert, L. Gonzalez, X. Calvet, N. Garcia, T. Lopez, and M. Roque Proton pump inhibitor, clarithromycin and either amoxycillin or nitroimidazole: a meta-analysis of eradication of Helicobacter pylori Aliment Pharmacol Ther 14 2000 1319 1328
185. J.P. Gisbert, and J.M. Pajares [Helicobacter pylori resistance to metronidazole and to clarithromycin in Spain. A systematic review] Med Clin (Barc) 116 2001 111 116
186. M. Rodriguez-Torres, R. Salgado-Mercado, C.F. Rios-Bedoya, E. Aponte-Rivera, A.M. Marxuach-Cuetara, and J.F. Rodriguez-Orengo High eradication rates of Helicobacter pylori infection with first- and second-line combination of esomeprazole, tetracycline, and metronidazole in patients allergic to penicillin Dig Dis Sci 50 2005 634 639
187. M. Vallve, M. Vergara, J.P. Gisbert, and X. Calvet Single vs. double dose of a proton pump inhibitor in triple therapy for Helicobacter pylori eradication: a meta-analysis Aliment Pharmacol Ther 16 2002 1149 1156
188. S. Padol, Y. Yuan, M. Thabane, I.T. Padol, and R.H. Hunt The effect of CYP2C19 polymorphisms on H. pylori eradication rate in dual and triple first-line PPI therapies: a meta-analysis Am J Gastroenterol 101 2006 1467 1475
189. A. Villoria, P. Garcia, X. Calvet, J.P. Gisbert, and M. Vergara Meta-analysis: high-dose proton pump inhibitors vs. standard dose in triple therapy for Helicobacter pylori eradication Aliment Pharmacol Ther 28 2008 868 877
190. McNicholl AG, Muñoz Linares P, Pérez Nyssen O, Calvet X, Gisbert JP. Meta-analysis: rabeprazole and esomeprazole in the eradication of Helicobacter pylori. Helicobacter 2011, en prensa.
191. X. Calvet, N. Garcia, T. Lopez, J.P. Gisbert, E. Gené, and M. Roque A meta-analysis of short versus long therapy with a proton pump inhibitor, clarithromycin and either metronidazole or amoxycillin for treating Helicobacter pylori infection Aliment Pharmacol Ther 14 2000 603 609
192. A. Ford, and P. Moayyedi How can the current strategies for Helicobacter pylori eradication therapy be improved? Can J Gastroenterol 17 Suppl. B 2003 36B 40B
193. L. Fuccio, M.E. Minardi, R.M. Zagari, D. Grilli, N. Magrini, and F. Bazzoli Meta-analysis: duration of first-line proton-pump inhibitor based triple therapy for Helicobacter pylori eradication Ann Intern Med 147 2007 553 562
194. H.B. Flores, A. Salvana, E.L.R. Ang, N.I. Estanislao, M.E. Velasquez, and J. Ong Duration of Proton-Pump Inhibitor-Based Triple Therapy for Helicobacter pylori Eradication: a Meta-Analysis Gastroenterology 138 Suppl. 1 2010 M1138
195. X. Calvet, A. Villoria, and M. Vergara Could increasing the duration of triple therapy be a clinically useful strategy? Ann Intern Med 148 2008 624
196. J.P. Gisbert, and J.M. Pajares Review article: Helicobacter pylori "rescue" regimen when proton pump inhibitor-based triple therapies fail Aliment Pharmacol Ther 16 2002 1047 1057
197. J.P. Gisbert "Rescue" regimens after Helicobacter pylori treatment failure World J Gastroenterol 14 2008 5385 5402
198. J.P. Gisbert, F. Bermejo, M. Castro-Fernandez, A. Perez-Aisa, M. Fernandez-Bermejo, and A. Tomas Second-line rescue therapy with levofloxacin after H. pylori treatment failure: a Spanish multicenter study of 300 patients Am J Gastroenterol 103 2008 71 76
199. J.P. Gisbert, and F. Morena Systematic review and meta-analysis: levofloxacin-based rescue regimens after Helicobacter pylori treatment failure Aliment Pharmacol Ther 23 2006 35 44
200. R.J. Saad, P. Schoenfeld, H.M. Kim, and W.D. Chey Levofloxacin-based triple therapy versus bismuth-based quadruple therapy for persistent Helicobacter pylori infection: a meta-analysis Am J Gastroenterol 101 2006 488 496
201. A.C. Marín, A.G. McNicholl, and J.P. Gisbert Metaanálisis de triple terapia con levofloxacino vs. cuádruple terapia con bismuto como tratamientos de rescate de segunda línea para la erradicación de Helicobacter pylori Gastroenterol Hepatol 34 2011 235
202. J.P. Gisbert, A. Pérez-Aisa, F. Bermejo, P. Almela, M. Castro-Fernández, and J. Barrio Terapia de rescate con levofloxacino tras el fracaso erradicador de H. pylori: estudio multicéntrico de la Asociación Española de Gastroenterología sobre la eficacia y evolución temporal en 830 pacientes Gastroenterol Hepatol 34 2011 234
203. A. Zullo, C. Hassan, F. Cristofari, C. Iegri, and V. De Francesco How to manage Helicobacter pylori after sequential therapy failure? J Clin Gastroenterol 44 2010 459 460
204. Gisbert JP, Vinagre-Rodriguez G, Marín AC, Molina-Infante J. Second-line rescue triple therapy with levofloxacin after quadruple non-bismuth "sequential" or "concomitant" treatment failure. Helicobacter. En prensa.
205. J.P. Gisbert, M. Castro-Fernandez, F. Bermejo, A. Perez-Aisa, J. Ducons, and M. Fernandez-Bermejo Third-line rescue therapy with levofloxacin after two H. pylori treatment failures Am J Gastroenterol 101 2006 243 247
206. F. Megraud, and H. Lamouliatte Review article: the treatment of refractory Helicobacter pylori infection Aliment Pharmacol Ther 17 2003 1333 1343
207. F. Canducci, V. Ojetti, P. Pola, G. Gasbarrini, and A. Gasbarrini Rifabutin-based Helicobacter pylori eradication 'rescue therapy' Aliment Pharmacol Ther 15 2001 143
208. J.P. Gisbert, X. Calvet, L. Bujanda, S. Marcos, J.L. Gisbert, and J.M. Pajares "Rescue" therapy with rifabutin after multiple Helicobacter pylori treatment failures Helicobacter 8 2003 90 94
209. J.P. Gisbert, J.L. Gisbert, S. Marcos, R. Moreno-Otero, and J.M. Pajares Third-line rescue therapy with levofloxacin is more effective than rifabutin rescue regimen after two Helicobacter pylori treatment failures Aliment Pharmacol Ther 24 2006 1469 1474
210. P.S. Phull, D. Halliday, A.B. Price, and M.R. Jacyna Absence of dyspeptic symptoms as a test of Helicobacter pylori eradication BMJ 312 1996 349 350
211. J.P. Gisbert, and J.M. Pajares Systematic review and meta-analysis: is 1-week proton pump inhibitor-based triple therapy sufficient to heal peptic ulcer? Aliment Pharmacol Ther 21 2005 795 804
212. K. Higuchi, Y. Fujiwara, K. Tominaga, T. Watanabe, M. Shiba, and S. Nakamura Is eradication sufficient to heal gastric ulcers in patients infected with Helicobacter pylori?. A randomized, controlled, prospective study Aliment Pharmacol Ther 17 2003 111 117
213. K.C. Lai, W.M. Hui, B.C. Wong, W.H. Hu, and S.K. Lam Ulcer-healing drugs are required after eradication of Helicobacter pylori in patients with gastric ulcer but not duodenal ulcer haemorrhage Aliment Pharmacol Ther 14 2000 1071 1076
214. J.P. Gisbert, X. Calvet, A. Cosme, P. Almela, F. Feu, and F. Bory Erradicación de H. pylori y prevención de la recidiva hemorrágica por úlcera péptica. Estudio multicéntrico nacional a largo plazo en 890 pacientes Gastroenterol Hepatol 34 2011 236
215. S. Halder, and N.J. Talley Functional dispepsia: A new Rome III paradigm Current Treatment Options in Gastroenterology 10 2007 259 274
216. J. Keohane, and E.M.M. Quigley Functional dyspepsia: The role of visceral hypersensitivity in its patogénesis World J Gastroenterol 12 2006 2672 2676
217. K.J. Lee, S. Kindt, and J. Tack Pathophysiology of functional dyspepsia Best Pract Res Clin Gastroenterol 18 2004 707 716
218. F. Mearin, A. Perelló, and A. Balboa Trastornos funcionales y motores digestivos Gastroenterol Hepatol Monogr 3 2005 21 34
219. F. Mearin, M. Perez-Oliveras, A. Perello, J. Vinyet, A. Ibañez, and J. Coderch Dyspepsia and irritable bowel syndrome after a Salmonella gastroenteritis outbreak: one-year follow-up cohort study Gastroenterology 129 2005 98 104
220. Y. Mizuta, S. Shikuwa, H. Isomoto, R. Mishima, Y. Akazawa, and J. Masuda Recent insights into digestive motility in functional dyspepsia J Gastroenterol 41 2006 1025 1040
221. G. Sarnelli, R. Cuomo, J. Janssens, and J. Tack Symptom patterns and pathophysiological mechanisms in dyspeptic patients with and without helicobacter pylori Digestiva Diseases and Sciences 48 2003 2229 2236
222. V. Stanghellini, C. Tosetti, A. Paternic, G. Barbara, A.M. Morselli-Labate, and N. Monetti Risk indicators of delayed gastric emptying of solids in patients with functional dyspepsia Gastroenterology 110 1996 1036 1042
223. J. Tack, P. Caenepeel, B. Fischler, H. Piessevaux, and J. Janssens Symptoms associated with hypersensitivity to gastric distention in functional dyspepsia Gastroenterology 121 2001 526 535
224. J. Tack, I. Demedts, G. Dehondt, P. Caenepeel, B. Fischler, and M. Zandecki Clinical and pathophysiological characteristics of acute-onset functional dyspepsia Gastroenterology 122 2002 1738 1747
225. T. Thumshirm Pathophysiology of functional dyspepsia Gut 51 2002 63 66
226. J. Danesh, M. Lawrence, M. Murphy, S. Roberts, and R. Collins Systematic review of the epidemiological evidence on Helicobacter pylori infection and nonulcer or uninvestigated dyspepsia Arch Intern Med 160 2000 1192 1198
227. R.L. Jaakkimainen, E. Boyle, and F. Tudiver Is Helicobacter pylori associated with non-ulcer dyspepsia and will eradication improve symptoms? A meta-analysis BMJ 319 1999 1040 1044
228. L. Laine, P. Schoenfeld, and M.B. Fennerty Therapy for Helicobacter pylori in patients with nonulcer dyspepsia. A meta-analysis of randomized, controlled trials Ann Intern Med 134 2001 361 369
229. J.P. Gisbert, X. Calvet, R. Gabriel, and J.M. Pajares Infección por Helicobacter pylori y dispepsia funcional. Metaanálisis de la eficacia del tratamiento erradicador Med Clin (Barc) 118 2002 405 409
230. P.I. Hsu, K.H. Lai, H.H. Tseng, G.H. Lo, C.C. Lo, and C.K. Lin Eradication of Helicobacter pylori prevents ulcer development in patients with ulcer-like functional dyspepsia Aliment Pharmacol Ther 15 2001 195 201
231. H.R. Koelz, R. Arnold, M. Stolte, M. Fischer, A.L. Blum The Frosch Study Group Treatment of Helicobacter pylori in functional dispepsia resistant to conventional management: a double blind randomised trial with a six month follow up Gut 52 2003 40 46
232. N.S. Abraham, P. Moayyedi, B. Daniels, and S.J. Veldhuyzen Van Zanten Systematic review: the methodological quality of trials affects estimates of treatment efficacy in functional (nonulcer) dyspepsia Aliment Pharmacol Ther 19 2004 631 641
233. P. Moayyedi, J. Deeks, N.J. Talley, B. Delaney, and D. Forman An update of the Cochrane systematic review of Helicobacter pylori eradication therapy in nonulcer dyspepsia: resolving the discrepancy between systematic reviews Am J Gastroenterol 98 2003 2621 2626
234. P. Moayyedi, S. Soo, J. Deeks, B. Delaney, A. Harris, and M. Innes Eradication of Helicobacter pylori for non-ulcer dyspepsia. [update of Cochrane Database Syst Rev 2001;CD002096 PMID 11279751] Cochrane Database Syst Rev 2003 CD002096
235. P. Moayyedi, S. Soo, J. Deeks, B. Delaney, M. Innes, and D. Forman Pharmacological interventions for non-ulcer dyspepsia Cochrane Database Syst Rev 2006 CD001960
236. H.A. Redstone, N. Barrowman, and S.J. Veldhuyzen Van Zanten H2-receptor antagonists in the treatment of functional (nonulcer) dyspepsia: a meta-analysis of randomized controlled clinical trials Aliment Pharmacol Ther 15 2001 1291 1299
237. W.H. Wang, J.Q. Huang, G.F. Zheng, H.H. Xia, W.M. Wong, and X.G. Liu Effects of proton-pump inhibitors on functional dyspepsia: a meta-analysis of randomized placebo-controlled trials Clin Gastroenterol Hepatol 5 2007 178 185
238. N.J. Talley, and K. Lauritsen The potential role of acid suppression in functional dyspepsia: the BOND OPERA PILOT and ENCORE studies Gut 50 2002 36 41
239. T. Hiyama, M. Yoshihara, K. Matsuo, H. Kusunoki, T. Kamada, and M. Ito Meta-analysis of the effects of prokinetic agents in patients with functional dyspepsia J Gastroenterol Hepatol 22 2007 304 310
240. T. Hiyama, M. Yoshihara, K. Matsuo, H. Kusunoki, T. Kamada, and M. Ito Treatment of functional dyspepsia with serotonin agonists: a meta-analysis of randomized controlled trials J Gastroenterol Hepatol 22 2007 1566 1570
241. J. Tack Prokinetics and fundic relaxants in upper functional GI disorders Curr Opin Pharmacol 8 2008 690 696
242. J.L. Jackson, P.G. O'Malley, G. Tomkins, E. Balden, J. Santoro, and K. Kroenke Treatment of functional gastrointestinal disorders with antidepressant medications: a meta-analysis Am J Med 108 2000 65 72
243. J. Tack, D. Broekaert, B. Coulie, B. Fischler, and J. Janssens Influence of the selective serotonin re uptake inhibitor, paroxetine, on gastric sensorimotor function in humans Aliment Phamacol Ther 17 2003 603 608
244. N.J. Talley, L. Herrick, and G.R. Locke Antidepressants in functional dyspepsia Expert Rev Gastroenterol Hepatol 4 2010 5 8
245. M. Hojo, H. Miwa, T. Yokohama, T. Ohkusa, A. Nagahara, and M. Kawabe Treatment of functional dyspepsia with anxiety or antidepressive agents: systematic review J Gastroenterol 40 2005 1036 1042
246. L.A. Van Kerkhoven, R.J. Laheij, N. Aparicio, W.A. De Boer, S. Van den Hazel, and A.C. Tan Effect of the antidepressant venlafaxine in functional dyspepsia: a randomized, double-blind, placebo-controlled trial Clin Gastroenterol Hepatol 6 2008 746 752
247. S. Soo, P. Moayyedi, J. Deeks, B. Delaney, M. Lewis, and D. Forman Psychological interventions for non-ulcer dyspepsia Cochrane Database Syst Rev 2005 CD002301
248. M. Bixquert-Jiménez, and L. Bixquert-Pla Tratamiento con antidepresivos en los trastornos funcionales digestivos Gastroenterol Hepatol 28 2005 485 492
249. F. Cremonini, S. Delgado-Aros, and N.J. Talley Functional dyspepsia: drugs for new (and old) therapeutic targets Best Practice & Research Clinical Gastroenterology 18 2004 717 733
250. R.J. Saad, and W.D. Chey Current and emerging therapies for functional dyspepsia Aliment Pharmacol Ther 24 2006 475 492
251. S. Haag, W. Senf, S. Tagay, M. Langkafel, U. Braun-Lang, and A. Pietsch Is there a benefit from intensified medical and psychological interventions in patients with functional dyspepsia not responding to conventional therapy? Aliment Pharmacol Ther 25 2007 973 986
252. J. Thompson, and E. Ernst Systematic review: herbal medicinal products for non-ulcer dyspepsia Aliment Pharmacol Ther 16 2002 1689 1699
253. B. Kliger, and S. Chuadhary Peppermint oil Am Fam Physician 75 2007 1027 1030
254. J. Melzer, W. Rösch, J. Reichling, R. Brignoli, and R. Saller Meta-analysis: phytotherapy of functional dyspepsia with the herbal drug preparation STW 5 (Iberogast) Aliment Pharmacol Ther 20 2004 1279 1287
255. U. Von Arnim, U. Peitz, B. Vinson, K.L. Gundermann, and P. Malfertheiner STW 5, a Phytopharmacon for Patients With Functional Dyspepsia: Results of a Multicenter, Placebo-Controlled Double-Blind Study Am J Gastroenterol 102 2007 1268 1275
256. L. Lan, F. Zeng, G.J. Liu, L. Ying, X. Wu, and L.M. Liu Acupuncture for functional dyspepsia. Cochrane Database of Systematic Reviews 2010 Art. No.: CD008487